VanEck Pharmaceutical ETF
Limited financial coverage for PPH.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
About the company
VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
- IPO
- 2000
- HQ
- New York, NY, US
Price Chart
- Market Cap
- $657.77M
- Div Yield
- 1.95%
- 52W High
- $112.58
- 52W Low
- $81.74
- 50D MA
- $103.70
- 200D MA
- $101.65
- Beta
- 0.44
- Avg Volume
- 223.82K
Get TickerSpark's AI analysis on PPH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our PPH coverage
Recent articles, reports, and earnings notes.
No research on PPH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PPH report →Similar companies
Peers in the same neighborhood.